Can glucose‐lowering medications improve outcomes in non‐diabetic heart failure patients? A Bayesian network meta‐analysis

Can glucose‐lowering medications improve outcomes in non‐diabetic heart failure patients? A Bayesian network meta‐analysis

Abstract Aims The cardioprotective effects of glucose‐lowering medications in diabetic patients with heart failure (HF) are well known. Several large randomized controlled trials (RCTs) have recently suggested that the cardioprotective effects of glucose‐lowering medications extend to HF patients re...

Full description

Bibliographic Details
Main Authors: Trevor Yeong, Aaron Shengting Mai, Oliver Z.H. Lim, Cheng Han Ng, Yip Han Chin, Phoebe Tay, Chaoxing Lin, Mark Muthiah, Chin Meng Khoo, Mayank Dalakoti, Poay‐Huan Loh, Mark Chan, Tiong‐Cheng Yeo, Roger Foo, Raymond Wong, Nicholas W.S. Chew, Weiqin Lin
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:ESC Heart Failure
Subjects:
Heart failure
Sodium‐glucose cotransporter 2 inhibitors
Glucagon‐like peptide 1 receptor agonists
Metformin
Online Access:https://doi.org/10.1002/ehf2.13822

Internet

https://doi.org/10.1002/ehf2.13822

Similar Items